PMID,Title,Authors,Citation,First Author,Journal/Book,Publication Year,Create Date,PMCID,NIHMS ID,DOI
"35081293","Homologous and Heterologous Covid-19 Booster Vaccinations","Atmar RL, Lyke KE, Deming ME, Jackson LA, Branche AR, El Sahly HM, Rostad CA, Martin JM, Johnston C, Rupp RE, Mulligan MJ, Brady RC, Frenck RW Jr, Bäcker M, Kottkamp AC, Babu TM, Rajakumar K, Edupuganti S, Dobrzynski D, Coler RN, Posavad CM, Archer JI, Crandon S, Nayak SU, Szydlo D, Zemanek JA, Dominguez Islas CP, Brown ER, Suthar MS, McElrath MJ, McDermott AB, O'Connell SE, Montefiori DC, Eaton A, Neuzil KM, Stephens DS, Roberts PC, Beigel JH; DMID 21-0012 Study Group.","N Engl J Med. 2022 Mar 17;386(11):1046-1057. doi: 10.1056/NEJMoa2116414. Epub 2022 Jan 26.","Atmar RL","N Engl J Med","2022","2022/01/26","PMC8820244","","10.1056/NEJMoa2116414"
"35798000","Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant","Lyke KE, Atmar RL, Islas CD, Posavad CM, Szydlo D, Paul Chourdhury R, Deming ME, Eaton A, Jackson LA, Branche AR, El Sahly HM, Rostad CA, Martin JM, Johnston C, Rupp RE, Mulligan MJ, Brady RC, Frenck RW Jr, Bäcker M, Kottkamp AC, Babu TM, Rajakumar K, Edupuganti S, Dobrzynski D, Coler RN, Archer JI, Crandon S, Zemanek JA, Brown ER, Neuzil KM, Stephens DS, Post DJ, Nayak SU, Suthar MS, Roberts PC, Beigel JH, Montefiori DC; DMID 21-0012 Study Group.","Cell Rep Med. 2022 Jul 19;3(7):100679. doi: 10.1016/j.xcrm.2022.100679. Epub 2022 Jun 20.","Lyke KE","Cell Rep Med","2022","2022/07/07","PMC9212999","","10.1016/j.xcrm.2022.100679"
"33761206","Vaccine Efficacy of ALVAC-HIV and Bivalent Subtype C gp120-MF59 in Adults","Gray GE, Bekker LG, Laher F, Malahleha M, Allen M, Moodie Z, Grunenberg N, Huang Y, Grove D, Prigmore B, Kee JJ, Benkeser D, Hural J, Innes C, Lazarus E, Meintjes G, Naicker N, Kalonji D, Nchabeleng M, Sebe M, Singh N, Kotze P, Kassim S, Dubula T, Naicker V, Brumskine W, Ncayiya CN, Ward AM, Garrett N, Kistnasami G, Gaffoor Z, Selepe P, Makhoba PB, Mathebula MP, Mda P, Adonis T, Mapetla KS, Modibedi B, Philip T, Kobane G, Bentley C, Ramirez S, Takuva S, Jones M, Sikhosana M, Atujuna M, Andrasik M, Hejazi NS, Puren A, Wiesner L, Phogat S, Diaz Granados C, Koutsoukos M, Van Der Meeren O, Barnett SW, Kanesa-Thasan N, Kublin JG, McElrath MJ, Gilbert PB, Janes H, Corey L; HVTN 702 Study Team.","N Engl J Med. 2021 Mar 25;384(12):1089-1100. doi: 10.1056/NEJMoa2031499.","Gray GE","N Engl J Med","2021","2021/03/24","PMC7888373","","10.1056/NEJMoa2031499"
"33730454","Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition","Corey L, Gilbert PB, Juraska M, Montefiori DC, Morris L, Karuna ST, Edupuganti S, Mgodi NM, deCamp AC, Rudnicki E, Huang Y, Gonzales P, Cabello R, Orrell C, Lama JR, Laher F, Lazarus EM, Sanchez J, Frank I, Hinojosa J, Sobieszczyk ME, Marshall KE, Mukwekwerere PG, Makhema J, Baden LR, Mullins JI, Williamson C, Hural J, McElrath MJ, Bentley C, Takuva S, Gomez Lorenzo MM, Burns DN, Espy N, Randhawa AK, Kochar N, Piwowar-Manning E, Donnell DJ, Sista N, Andrew P, Kublin JG, Gray G, Ledgerwood JE, Mascola JR, Cohen MS; HVTN 704/HPTN 085 and HVTN 703/HPTN 081 Study Teams.","N Engl J Med. 2021 Mar 18;384(11):1003-1014. doi: 10.1056/NEJMoa2031738.","Corey L","N Engl J Med","2021","2021/03/17","PMC8189692","NIHMS1701559","10.1056/NEJMoa2031738"
"35758878","Analysis of the HIV Vaccine Trials Network 702 Phase 2b-3 HIV-1 Vaccine Trial in South Africa Assessing RV144 Antibody and T-Cell Correlates of HIV-1 Acquisition Risk","Moodie Z, Dintwe O, Sawant S, Grove D, Huang Y, Janes H, Heptinstall J, Omar FL, Cohen K, De Rosa SC, Zhang L, Yates NL, Sarzotti-Kelsoe M, Seaton KE, Laher F, Bekker LG, Malahleha M, Innes C, Kassim S, Naicker N, Govender V, Sebe M, Singh N, Kotze P, Lazarus E, Nchabeleng M, Ward AM, Brumskine W, Dubula T, Randhawa AK, Grunenberg N, Hural J, Kee JJ, Benkeser D, Jin Y, Carpp LN, Allen M, D'Souza P, Tartaglia J, DiazGranados CA, Koutsoukos M, Gilbert PB, Kublin JG, Corey L, Andersen-Nissen E, Gray GE, Tomaras GD, McElrath MJ.","J Infect Dis. 2022 Aug 24;226(2):246-257. doi: 10.1093/infdis/jiac260.","Moodie Z","J Infect Dis","2022","2022/06/27","PMC9890908","","10.1093/infdis/jiac260"
"29773020","Functions of IL-4 and Control of Its Expression","Brown MA, Hural J.","Crit Rev Immunol. 2017;37(2-6):181-212. doi: 10.1615/CritRevImmunol.v37.i2-6.30.","Brown MA","Crit Rev Immunol","2017","2018/05/19","","","10.1615/CritRevImmunol.v37.i2-6.30"
"25649349","HIV vaccine-induced sero-reactivity: a challenge for trial participants, researchers, and physicians","VISR Working Group of Global HIV Vaccine Enterprise; Voronin Y, Zinszner H, Karg C, Brooks K, Coombs R, Hural J, Holt R, Fast P, Allen M.","Vaccine. 2015 Mar 3;33(10):1243-9. doi: 10.1016/j.vaccine.2014.10.040. Epub 2015 Jan 31.","VISR Working Group of Global HIV Vaccine Enterprise","Vaccine","2015","2015/02/05","PMC4331207","NIHMS650683","10.1016/j.vaccine.2014.10.040"
"35353885","High Asymptomatic Carriage With the Omicron Variant in South Africa","Garrett N, Tapley A, Andriesen J, Seocharan I, Fisher LH, Bunts L, Espy N, Wallis CL, Randhawa AK, Miner MD, Ketter N, Yacovone M, Goga A, Huang Y, Hural J, Kotze P, Bekker LG, Gray GE, Corey L; Ubuntu Study Team.","Clin Infect Dis. 2022 Aug 24;75(1):e289-e292. doi: 10.1093/cid/ciac237.","Garrett N","Clin Infect Dis","2022","2022/03/30","PMC9383623","","10.1093/cid/ciac237"
"35995954","Neutralization titer biomarker for antibody-mediated prevention of HIV-1 acquisition","Gilbert PB, Huang Y, deCamp AC, Karuna S, Zhang Y, Magaret CA, Giorgi EE, Korber B, Edlefsen PT, Rossenkhan R, Juraska M, Rudnicki E, Kochar N, Huang Y, Carpp LN, Barouch DH, Mkhize NN, Hermanus T, Kgagudi P, Bekker V, Kaldine H, Mapengo RE, Eaton A, Domin E, West C, Feng W, Tang H, Seaton KE, Heptinstall J, Brackett C, Chiong K, Tomaras GD, Andrew P, Mayer BT, Reeves DB, Sobieszczyk ME, Garrett N, Sanchez J, Gay C, Makhema J, Williamson C, Mullins JI, Hural J, Cohen MS, Corey L, Montefiori DC, Morris L.","Nat Med. 2022 Sep;28(9):1924-1932. doi: 10.1038/s41591-022-01953-6. Epub 2022 Aug 22.","Gilbert PB","Nat Med","2022","2022/08/22","PMC9499869","","10.1038/s41591-022-01953-6"
"36136590","Lower SARS-CoV-2-specific humoral immunity in people living with HIV-1 recovered from nonhospitalized COVID-19","Schuster DJ, Karuna S, Brackett C, Wesley M, Li SS, Eisel N, Tenney D, Hilliard S, Yates NL, Heptinstall JR, Williams LD, Shen X, Rolfe R, Cabello R, Zhang L, Sawant S, Hu J, Randhawa AK, Hyrien O, Hural JA, Corey L, Frank I, Tomaras GD, Seaton KE; HVTN 405/HPTN 1901 Study Team.","JCI Insight. 2022 Nov 8;7(21):e158402. doi: 10.1172/jci.insight.158402.","Schuster DJ","JCI Insight","2022","2022/09/22","PMC9675463","","10.1172/jci.insight.158402"
"37300931","Pharmacokinetic serum concentrations of VRC01 correlate with prevention of HIV-1 acquisition","Seaton KE, Huang Y, Karuna S, Heptinstall JR, Brackett C, Chiong K, Zhang L, Yates NL, Sampson M, Rudnicki E, Juraska M, deCamp AC, Edlefsen PT, Mullins JI, Williamson C, Rossenkhan R, Giorgi EE, Kenny A, Angier H, Randhawa A, Weiner JA, Rojas M, Sarzotti-Kelsoe M, Zhang L, Sawant S, Ackerman ME, McDermott AB, Mascola JR, Hural J, McElrath MJ, Andrew P, Hidalgo JA, Clark J, Laher F, Orrell C, Frank I, Gonzales P, Edupuganti S, Mgodi N, Corey L, Morris L, Montefiori D, Cohen MS, Gilbert PB, Tomaras GD.","EBioMedicine. 2023 Jul;93:104590. doi: 10.1016/j.ebiom.2023.104590. Epub 2023 Jun 8.","Seaton KE","EBioMedicine","2023","2023/06/10","PMC10363420","","10.1016/j.ebiom.2023.104590"
"37384759","Neutralization profiles of HIV-1 viruses from the VRC01 Antibody Mediated Prevention (AMP) trials","Mkhize NN, Yssel AEJ, Kaldine H, van Dorsten RT, Woodward Davis AS, Beaume N, Matten D, Lambson B, Modise T, Kgagudi P, York T, Westfall DH, Giorgi EE, Korber B, Anthony C, Mapengo RE, Bekker V, Domin E, Eaton A, Deng W, DeCamp A, Huang Y, Gilbert PB, Gwashu-Nyangiwe A, Thebus R, Ndabambi N, Mielke D, Mgodi N, Karuna S, Edupuganti S, Seaman MS, Corey L, Cohen MS, Hural J, McElrath MJ, Mullins JI, Montefiori D, Moore PL, Williamson C, Morris L.","PLoS Pathog. 2023 Jun 29;19(6):e1011469. doi: 10.1371/journal.ppat.1011469. eCollection 2023 Jun.","Mkhize NN","PLoS Pathog","2023","2023/06/29","PMC10337935","","10.1371/journal.ppat.1011469"
"34907214","Calibration of two validated SARS-CoV-2 pseudovirus neutralization assays for COVID-19 vaccine evaluation","Huang Y, Borisov O, Kee JJ, Carpp LN, Wrin T, Cai S, Sarzotti-Kelsoe M, McDanal C, Eaton A, Pajon R, Hural J, Posavad CM, Gill K, Karuna S, Corey L, McElrath MJ, Gilbert PB, Petropoulos CJ, Montefiori DC.","Sci Rep. 2021 Dec 14;11(1):23921. doi: 10.1038/s41598-021-03154-6.","Huang Y","Sci Rep","2021","2021/12/15","PMC8671391","","10.1038/s41598-021-03154-6"
"33511233","Poststudy Point-of-Care Oral Fluid Testing in Human Immunodeficiency Virus-1 Vaccinees","Oganezova K, Fontana-Martinez EJ, Gothing JA, Pandit A, Kwara E, Yanosick K, Dragavon J, Goecker EA, Maenza J, Espy N, Tomaka F, Lavreys L, Allen M, D'Souza P, Hural J, Coombs RW, Dolin R, Seaman MS, Walsh SR, Baden LR.","Open Forum Infect Dis. 2020 Dec 15;8(1):ofaa606. doi: 10.1093/ofid/ofaa606. eCollection 2021 Jan.","Oganezova K","Open Forum Infect Dis","2020","2021/01/29","PMC7813203","","10.1093/ofid/ofaa606"
"35547849","Safety and Immunogenicity of a Third Dose of SARS-CoV-2 mRNA Vaccine â€"" An Interim Analysis","Anderson E, Jackson L, Rouphael N, Widge A, Montefiori D, Doria-Rose N, Suthar M, Cohen K, O'Connell S, Makowski M, Makhene M, Buchanan W, Spearman P, Creech CB, O'Dell S, Schmidt S, Leav B, Bennett H, Pajon R, Posavad C, Hural J, Beigel J, Albert J, Abebe K, Eaton A, Rostad C, Rebolledo P, Kamidani S, Graciaa D, Coler R, McDermott A, Ledgerwood J, Mascola J, DeRosa S, Neuzil K, McElrath MJ, Roberts P.","Res Sq. 2022 May 3:rs.3.rs-1222037. doi: 10.21203/rs.3.rs-1222037/v1. Preprint.","Anderson E","Res Sq","2022","2022/05/13","PMC9094107","","10.21203/rs.3.rs-1222037/v1"
"34494017","Calibration of Two Validated SARS-CoV-2 Pseudovirus Neutralization Assays for COVID-19 Vaccine Evaluation","Huang Y, Borisov O, Kee JJ, Carpp LN, Wrin T, Cai S, Sarzotti-Kelsoe M, McDanal C, Eaton A, Pajon R, Hural J, Posavad CM, Gill K, Karuna S, Corey L, McElrath MJ, Gilbert PB, Petropoulos CJ, Montefiori DC.","Res Sq. 2021 Sep 2:rs.3.rs-862572. doi: 10.21203/rs.3.rs-862572/v1. Preprint.","Huang Y","Res Sq","2021","2021/09/08","PMC8423224","","10.21203/rs.3.rs-862572/v1"
"34545372","Calibration of Two Validated SARS-CoV-2 Pseudovirus Neutralization Assays for COVID-19 Vaccine Evaluation","Huang Y, Borisov O, Kee JJ, Carpp LN, Wrin T, Cai S, Sarzotti-Kelsoe M, McDanal C, Eaton A, Pajon R, Hural J, Posavad CM, Gill K, Karuna S, Corey L, McElrath MJ, Gilbert PB, Petropoulos CJ, Montefiori DC.","medRxiv. 2021 Sep 14:2021.09.09.21263049. doi: 10.1101/2021.09.09.21263049. Preprint.","Huang Y","medRxiv","2021","2021/09/21","PMC8452111","","10.1101/2021.09.09.21263049"
"35866359","Achieving intracellular cytokine staining assay concordance on two continents to assess HIV vaccine-induced T-cell responses","Dintwe OB, De Rosa SC, Huang Y, Flach BS, Manso B, Carter D, Omar FL, Schwedhelm KV, Yu C, Lu H, Morris D, Kee JJ, Voillet V, Stirewalt M, Hural J, Moodie Z, Frahm N, Cohen KW, McElrath MJ, Andersen-Nissen E.","J Leukoc Biol. 2022 Nov;112(5):1167-1181. doi: 10.1002/JLB.5MA0522-668R. Epub 2022 Jul 22.","Dintwe OB","J Leukoc Biol","2022","2022/07/22","PMC10229754","NIHMS1894529","10.1002/JLB.5MA0522-668R"
"37289667","Cross-protocol assessment of induction and durability of VISP/R in HIV preventive vaccine trial participants","Espy N, Han X, Grant S, Kwara E, Lakshminarayanan B, Stirewalt M, Seaton KE, Tomaras GD, Goecker E, McElrath J, Andriesen J, Huang Y, Walsh SR, Hural J.","PLOS Glob Public Health. 2023 Jun 8;3(6):e0002037. doi: 10.1371/journal.pgph.0002037. eCollection 2023.","Espy N","PLOS Glob Public Health","2023","2023/06/08","PMC10249892","","10.1371/journal.pgph.0002037"
"31534016","Immune correlates of the Thai RV144 HIV vaccine regimen in South Africa","Gray GE, Huang Y, Grunenberg N, Laher F, Roux S, Andersen-Nissen E, De Rosa SC, Flach B, Randhawa AK, Jensen R, Swann EM, Bekker LG, Innes C, Lazarus E, Morris L, Mkhize NN, Ferrari G, Montefiori DC, Shen X, Sawant S, Yates N, Hural J, Isaacs A, Phogat S, DiazGranados CA, Lee C, Sinangil F, Michael NL, Robb ML, Kublin JG, Gilbert PB, McElrath MJ, Tomaras GD, Corey L.","Sci Transl Med. 2019 Sep 18;11(510):eaax1880. doi: 10.1126/scitranslmed.aax1880.","Gray GE","Sci Transl Med","2019","2019/09/20","PMC7199879","NIHMS1054745","10.1126/scitranslmed.aax1880"
"34923559","Infusion Reactions After Receiving the Broadly Neutralizing Antibody VRC01 or Placebo to Reduce HIV-1 Acquisition: Results From the Phase 2b Antibody-Mediated Prevention Randomized Trials","Takuva S, Karuna ST, Juraska M, Rudnicki E, Edupuganti S, Anderson M, De La Grecca R, Gaudinski MR, Sehurutshi A, Orrell C, Naidoo L, Valencia J, Villela LM, Walsh SR, Andrew P, Karg C, Randhawa A, Hural J, Gomez Lorenzo MM, Burns DN, Ledgerwood J, Mascola JR, Cohen M, Corey L, Mngadi K, Mgodi NM; HVTN 703/HPTN 081 and HVTN 704/HPTN 085 Study Teams.","J Acquir Immune Defic Syndr. 2022 Apr 1;89(4):405-413. doi: 10.1097/QAI.0000000000002892.","Takuva S","J Acquir Immune Defic Syndr","2022","2021/12/19","PMC9555144","NIHMS1764280","10.1097/QAI.0000000000002892"
"35301794","Development of flow cytometry-based assays to assess the ability of antibodies to bind to SARS-CoV-2-infected and spike-transfected cells and mediate NK cell degranulation","Mielke D, Stanfield-Oakley S, Jha S, Keyes T, Zalaquett A, Dunn B, Rodgers N, Oguin T, Sempowski GD, Binder RA, Gray GC, Karuna S, Corey L, Hural J, Tomaras GD, Pollara J, Ferrari G.","Cytometry A. 2022 Jun;101(6):483-496. doi: 10.1002/cyto.a.24552. Epub 2022 Apr 1.","Mielke D","Cytometry A","2022","2022/03/18","PMC9087172","NIHMS1790461","10.1002/cyto.a.24552"
"24099601","Efficacy trial of a DNA/rAd5 HIV-1 preventive vaccine","Hammer SM, Sobieszczyk ME, Janes H, Karuna ST, Mulligan MJ, Grove D, Koblin BA, Buchbinder SP, Keefer MC, Tomaras GD, Frahm N, Hural J, Anude C, Graham BS, Enama ME, Adams E, DeJesus E, Novak RM, Frank I, Bentley C, Ramirez S, Fu R, Koup RA, Mascola JR, Nabel GJ, Montefiori DC, Kublin J, McElrath MJ, Corey L, Gilbert PB; HVTN 505 Study Team.","N Engl J Med. 2013 Nov 28;369(22):2083-92. doi: 10.1056/NEJMoa1310566. Epub 2013 Oct 7.","Hammer SM","N Engl J Med","2013","2013/10/09","PMC4030634","NIHMS552686","10.1056/NEJMoa1310566"
"34166231","Rectal tissue and vaginal tissue from intravenous VRC01 recipients show protection against ex vivo HIV-1 challenge","Astronomo RD, Lemos MP, Narpala SR, Czartoski J, Fleming LB, Seaton KE, Prabhakaran M, Huang Y, Lu Y, Westerberg K, Zhang L, Gross MK, Hural J, Tieu HV, Baden LR, Hammer S, Frank I, Ochsenbauer C, Grunenberg N, Ledgerwood JE, Mayer K, Tomaras G, McDermott AB, McElrath MJ.","J Clin Invest. 2021 Aug 16;131(16):e146975. doi: 10.1172/JCI146975.","Astronomo RD","J Clin Invest","2021","2021/06/24","PMC8363291","","10.1172/JCI146975"
"32747654","Impact of vaccine type on HIV-1 vaccine elicited antibody durability and B cell gene signature","Palli R, Seaton KE, Piepenbrink MS, Hural J, Goepfert PA, Laher F, Buchbinder SP, Churchyard G, Gray GE, Robinson HL, Huang Y, Janes H, Kobie JJ, Keefer MC, Tomaras GD, Thakar J.","Sci Rep. 2020 Aug 3;10(1):13031. doi: 10.1038/s41598-020-69007-w.","Palli R","Sci Rep","2020","2020/08/05","PMC7398916","","10.1038/s41598-020-69007-w"
"26322580","HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders","Janes H, Herbeck JT, Tovanabutra S, Thomas R, Frahm N, Duerr A, Hural J, Corey L, Self SG, Buchbinder SP, McElrath MJ, O'Connell RJ, Paris RM, Rerks-Ngarm S, Nitayaphan S, Pitisuttihum P, Kaewkungwal J, Robb ML, Michael NL, Mullins JI, Kim JH, Gilbert PB, Rolland M.","Nat Med. 2015 Oct;21(10):1139-41. doi: 10.1038/nm.3932. Epub 2015 Aug 31.","Janes H","Nat Med","2015","2015/09/01","PMC4598284","NIHMS711050","10.1038/nm.3932"
"30615119","Rapid Boosting of HIV-1 Neutralizing Antibody Responses in Humans Following a Prolonged Immunologic Rest Period","Spearman P, Tomaras GD, Montefiori DC, Huang Y, Elizaga ML, Ferrari G, Alam SM, Isaacs A, Ahmed H, Hural J, McElrath MJ, Ouedraogo L, Pensiero M, Butler C, Kalams SA, Overton ET, Barnett SW; HVTN 088 Protocol Team and the NIH/NIAID HIV Vaccine Trials Network.","J Infect Dis. 2019 May 5;219(11):1755-1765. doi: 10.1093/infdis/jiz008.","Spearman P","J Infect Dis","2019","2019/01/08","PMC6775047","","10.1093/infdis/jiz008"
"33587505","Feasibility and Successful Enrollment in a Proof-of-Concept HIV Prevention Trial of VRC01, a Broadly Neutralizing HIV-1 Monoclonal Antibody","Edupuganti S, Mgodi N, Karuna ST, Andrew P, Rudnicki E, Kochar N, deCamp A, De La Grecca R, Anderson M, Karg C, Tindale I, Greene E, Broder GB, Lucas J, Hural J, Gallardo-Cartagena JA, Gonzales P, Frank I, Sobieszczyk M, Gomez Lorenzo MM, Burns D, Anderson PL, Miner MD, Ledgerwood J, Mascola JR, Gilbert PB, Cohen MS, Corey L; HVTN 704/HPTN 085 study group.","J Acquir Immune Defic Syndr. 2021 May 1;87(1):671-679. doi: 10.1097/QAI.0000000000002639.","Edupuganti S","J Acquir Immune Defic Syndr","2021","2021/02/15","PMC8397466","NIHMS1667238","10.1097/QAI.0000000000002639"
"31748227","Antigenic competition in CD4(+) T cell responses in a randomized, multicenter, double-blind clinical HIV vaccine trial","Kallas EG, Grunenberg NA, Yu C, Manso B, Pantaleo G, Casapia M, Baden LR, Valencia J, Sobieszczyk M, Van Tieu H, Allen M, Hural J, Graham BS, Kublin J, Gilbert PB, Corey L, Goepfert PA, McElrath MJ, Johnson RP, Huang Y, Frahm N.","Sci Transl Med. 2019 Nov 20;11(519):eaaw1673. doi: 10.1126/scitranslmed.aaw1673.","Kallas EG","Sci Transl Med","2019","2019/11/22","PMC7003991","NIHMS1062357","10.1126/scitranslmed.aaw1673"
"25271627","HIV-specific humoral responses benefit from stronger prime in phase Ib clinical trial","Bart PA, Huang Y, Karuna ST, Chappuis S, Gaillard J, Kochar N, Shen X, Allen MA, Ding S, Hural J, Liao HX, Haynes BF, Graham BS, Gilbert PB, McElrath MJ, Montefiori DC, Tomaras GD, Pantaleo G, Frahm N.","J Clin Invest. 2014 Nov;124(11):4843-56. doi: 10.1172/JCI75894. Epub 2014 Oct 1.","Bart PA","J Clin Invest","2014","2014/10/02","PMC4347219","","10.1172/JCI75894"
"22492863","Preexisting adenovirus seropositivity is not associated with increased HIV-1 acquisition in three HIV-1 vaccine efficacy trials","Stephenson KE, Hural J, Buchbinder SP, Sinangil F, Barouch DH.","J Infect Dis. 2012 Jun 15;205(12):1806-10. doi: 10.1093/infdis/jis285. Epub 2012 Apr 5.","Stephenson KE","J Infect Dis","2012","2012/04/12","PMC3415893","","10.1093/infdis/jis285"
"29218117","Basis and Statistical Design of the Passive HIV-1 Antibody Mediated Prevention (AMP) Test-of-Concept Efficacy Trials","Gilbert PB, Juraska M, deCamp AC, Karuna S, Edupuganti S, Mgodi N, Donnell DJ, Bentley C, Sista N, Andrew P, Isaacs A, Huang Y, Zhang L, Capparelli E, Kochar N, Wang J, Eshleman SH, Mayer KH, Magaret CA, Hural J, Kublin JG, Gray G, Montefiori DC, Gomez MM, Burns DN, McElrath J, Ledgerwood J, Graham BS, Mascola JR, Cohen M, Corey L.","Stat Commun Infect Dis. 2017 Jan;9(1):20160001. doi: 10.1515/scid-2016-0001. Epub 2017 Jun 6.","Gilbert PB","Stat Commun Infect Dis","2017","2017/12/09","PMC5714515","NIHMS898295","10.1515/scid-2016-0001"
"33587510","A Phase 2b Study to Evaluate the Safety and Efficacy of VRC01 Broadly Neutralizing Monoclonal Antibody in Reducing Acquisition of HIV-1 Infection in Women in Sub-Saharan Africa: Baseline Findings","Mgodi NM, Takuva S, Edupuganti S, Karuna S, Andrew P, Lazarus E, Garnett P, Shava E, Mukwekwerere PG, Kochar N, Marshall K, Rudnicki E, Juraska M, Anderson M, Karg C, Tindale I, Greene E, Luthuli N, Baepanye K, Hural J, Gomez Lorenzo MM, Burns D, Miner MD, Ledgerwood J, Mascola JR, Donnell D, Cohen MS, Corey L; HVTN 703/HPTN 081 Team.","J Acquir Immune Defic Syndr. 2021 May 1;87(1):680-687. doi: 10.1097/QAI.0000000000002649.","Mgodi NM","J Acquir Immune Defic Syndr","2021","2021/02/15","PMC8436719","NIHMS1735905","10.1097/QAI.0000000000002649"
"21358627","Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial","Rolland M, Tovanabutra S, deCamp AC, Frahm N, Gilbert PB, Sanders-Buell E, Heath L, Magaret CA, Bose M, Bradfield A, O'Sullivan A, Crossler J, Jones T, Nau M, Wong K, Zhao H, Raugi DN, Sorensen S, Stoddard JN, Maust BS, Deng W, Hural J, Dubey S, Michael NL, Shiver J, Corey L, Li F, Self SG, Kim J, Buchbinder S, Casimiro DR, Robertson MN, Duerr A, McElrath MJ, McCutchan FE, Mullins JI.","Nat Med. 2011 Mar;17(3):366-71. doi: 10.1038/nm.2316. Epub 2011 Feb 27.","Rolland M","Nat Med","2011","2011/03/02","PMC3053571","NIHMS269267","10.1038/nm.2316"
"21179404","Equivalence of ELISpot assays demonstrated between major HIV network laboratories","Gill DK, Huang Y, Levine GL, Sambor A, Carter DK, Sato A, Kopycinski J, Hayes P, Hahn B, Birungi J, Tarragona-Fiol T, Wan H, Randles M, Cooper AR, Ssemaganda A, Clark L, Kaleebu P, Self SG, Koup R, Wood B, McElrath MJ, Cox JH, Hural J, Gilmour J.","PLoS One. 2010 Dec 14;5(12):e14330. doi: 10.1371/journal.pone.0014330.","Gill DK","PLoS One","2010","2010/12/24","PMC3001861","","10.1371/journal.pone.0014330"
"19536325","Evaluation and recommendations on good clinical laboratory practice guidelines for phase I-III clinical trials","Sarzotti-Kelsoe M, Cox J, Cleland N, Denny T, Hural J, Needham L, Ozaki D, Rodriguez-Chavez IR, Stevens G, Stiles T, Tarragona-Fiol T, Simkins A.","PLoS Med. 2009 May 26;6(5):e1000067. doi: 10.1371/journal.pmed.1000067. Epub 2009 May 5.","Sarzotti-Kelsoe M","PLoS Med","2009","2009/06/19","PMC2670502","","10.1371/journal.pmed.1000067"
"21619905","International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populations","Barouch DH, Kik SV, Weverling GJ, Dilan R, King SL, Maxfield LF, Clark S, Ng'ang'a D, Brandariz KL, Abbink P, Sinangil F, de Bruyn G, Gray GE, Roux S, Bekker LG, Dilraj A, Kibuuka H, Robb ML, Michael NL, Anzala O, Amornkul PN, Gilmour J, Hural J, Buchbinder SP, Seaman MS, Dolin R, Baden LR, Carville A, Mansfield KG, Pau MG, Goudsmit J.","Vaccine. 2011 Jul 18;29(32):5203-9. doi: 10.1016/j.vaccine.2011.05.025. Epub 2011 May 25.","Barouch DH","Vaccine","2011","2011/05/31","PMC3138857","NIHMS303269","10.1016/j.vaccine.2011.05.025"
"26475930","Vaccination With Heterologous HIV-1 Envelope Sequences and Heterologous Adenovirus Vectors Increases T-Cell Responses to Conserved Regions: HVTN 083","Walsh SR, Moodie Z, Fiore-Gartland AJ, Morgan C, Wilck MB, Hammer SM, Buchbinder SP, Kalams SA, Goepfert PA, Mulligan MJ, Keefer MC, Baden LR, Swann EM, Grant S, Ahmed H, Li F, Hertz T, Self SG, Friedrich D, Frahm N, Liao HX, Montefiori DC, Tomaras GD, McElrath MJ, Hural J, Graham BS, Jin X; HVTN 083 Study Group and the NIAID HVTN.","J Infect Dis. 2016 Feb 15;213(4):541-50. doi: 10.1093/infdis/jiv496. Epub 2015 Oct 15.","Walsh SR","J Infect Dis","2016","2015/10/18","PMC4721914","","10.1093/infdis/jiv496"
"31895881","A Phase 1 Randomized, Placebo-controlled, Observer-blinded Trial to Evaluate the Safety and Immunogenicity of Inactivated Streptococcus pneumoniae Whole-cell Vaccine in Adults","Keech CA, Morrison R, Anderson P, Tate A, Flores J, Goldblatt D, Briles D, Hural J, Malley R, Alderson MR.","Pediatr Infect Dis J. 2020 Apr;39(4):345-351. doi: 10.1097/INF.0000000000002567.","Keech CA","Pediatr Infect Dis J","2020","2020/01/03","","","10.1097/INF.0000000000002567"
"26761518","The Safety and Immunogenicity of an Interleukin-12-Enhanced Multiantigen DNA Vaccine Delivered by Electroporation for the Treatment of HIV-1 Infection","Jacobson JM, Zheng L, Wilson CC, Tebas P, Matining RM, Egan MA, Eldridge J, Landay AL, Clifford DB, Luetkemeyer AF, Tiu J, Martinez AL, Janik J, Spitz TA, Hural J, McElrath J, Frahm N; ACTG A5281 Protocol Team.","J Acquir Immune Defic Syndr. 2016 Feb 1;71(2):163-71. doi: 10.1097/QAI.0000000000000830.","Jacobson JM","J Acquir Immune Defic Syndr","2016","2016/01/14","PMC4712745","NIHMS717432","10.1097/QAI.0000000000000830"
"31095007","Daily Vaginal Swabs and Mobile Phone Sex Report for Assessing HIV Virion Exposure Prospectively Among a Cohort of Young Sexually Active Women in South Africa (HVTN 915)","Lemos MP, Lazarus E, Isaacs A, Dietrich J, Morgan C, Huang Y, Grove D, Andrasik M, Laher F, Hural J, Chung E, Dragavon J, Puren A, Gulati RK, Coombs R, McElrath MJ, Gray G, Kublin JG.","J Acquir Immune Defic Syndr. 2019 Jun 1;81(2):e39-e48. doi: 10.1097/QAI.0000000000002015.","Lemos MP","J Acquir Immune Defic Syndr","2019","2019/05/17","PMC6743720","NIHMS1522010","10.1097/QAI.0000000000002015"
"16959262","Statistical positivity criteria for the analysis of ELISpot assay data in HIV-1 vaccine trials","Moodie Z, Huang Y, Gu L, Hural J, Self SG.","J Immunol Methods. 2006 Aug 31;315(1-2):121-32. doi: 10.1016/j.jim.2006.07.015. Epub 2006 Aug 15.","Moodie Z","J Immunol Methods","2006","2006/09/09","","","10.1016/j.jim.2006.07.015"
"19012957","HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis","McElrath MJ, De Rosa SC, Moodie Z, Dubey S, Kierstead L, Janes H, Defawe OD, Carter DK, Hural J, Akondy R, Buchbinder SP, Robertson MN, Mehrotra DV, Self SG, Corey L, Shiver JW, Casimiro DR; Step Study Protocol Team.","Lancet. 2008 Nov 29;372(9653):1894-1905. doi: 10.1016/S0140-6736(08)61592-5. Epub 2008 Nov 13.","McElrath MJ","Lancet","2008","2008/11/18","PMC2774110","NIHMS109576","10.1016/S0140-6736(08)61592-5"
"28199679","Higher T-Cell Responses Induced by DNA/rAd5 HIV-1 Preventive Vaccine Are Associated With Lower HIV-1 Infection Risk in an Efficacy Trial","Janes HE, Cohen KW, Frahm N, De Rosa SC, Sanchez B, Hural J, Magaret CA, Karuna S, Bentley C, Gottardo R, Finak G, Grove D, Shen M, Graham BS, Koup RA, Mulligan MJ, Koblin B, Buchbinder SP, Keefer MC, Adams E, Anude C, Corey L, Sobieszczyk M, Hammer SM, Gilbert PB, McElrath MJ.","J Infect Dis. 2017 May 1;215(9):1376-1385. doi: 10.1093/infdis/jix086.","Janes HE","J Infect Dis","2017","2017/02/16","PMC5853653","","10.1093/infdis/jix086"
"21282192","Phase 1 safety and immunogenicity testing of DNA and recombinant modified vaccinia Ankara vaccines expressing HIV-1 virus-like particles","Goepfert PA, Elizaga ML, Sato A, Qin L, Cardinali M, Hay CM, Hural J, DeRosa SC, DeFawe OD, Tomaras GD, Montefiori DC, Xu Y, Lai L, Kalams SA, Baden LR, Frey SE, Blattner WA, Wyatt LS, Moss B, Robinson HL; National Institute of Allergy and Infectious Diseases HIV Vaccine Trials Network.","J Infect Dis. 2011 Mar 1;203(5):610-9. doi: 10.1093/infdis/jiq105. Epub 2011 Jan 31.","Goepfert PA","J Infect Dis","2011","2011/02/02","PMC3072720","","10.1093/infdis/jiq105"
"24403525","Performance of a redesigned HIV Selectest enzyme-linked immunosorbent assay optimized to minimize vaccine-induced seropositivity in HIV vaccine trial participants","Penezina O, Krueger NX, Rodriguez-Chavez IR, Busch MP, Hural J, Kim JH, O'Connell RJ, Hunter E, Aboud S, Higgins K, Kovalenko V, Clapham D, Crane D, Levin AE; HIV Selectest Study Group.","Clin Vaccine Immunol. 2014 Mar;21(3):391-8. doi: 10.1128/CVI.00748-13. Epub 2014 Jan 8.","Penezina O","Clin Vaccine Immunol","2014","2014/01/10","PMC3957658","","10.1128/CVI.00748-13"
"22496775","Decreased pre-existing Ad5 capsid and Ad35 neutralizing antibodies increase HIV-1 infection risk in the Step trial independent of vaccination","Cheng C, Wang L, Gall JG, Nason M, Schwartz RM, McElrath MJ, DeRosa SC, Hural J, Corey L, Buchbinder SP, Nabel GJ.","PLoS One. 2012;7(4):e33969. doi: 10.1371/journal.pone.0033969. Epub 2012 Apr 4.","Cheng C","PLoS One","2012","2012/04/13","PMC3319553","","10.1371/journal.pone.0033969"
"24709391","Benefits of a comprehensive quality program for cryopreserved PBMC covering 28 clinical trials sites utilizing an integrated, analytical web-based portal","Ducar C, Smith D, Pinzon C, Stirewalt M, Cooper C, McElrath MJ, Hural J; NIAID HIV Vaccine Trials Network.","J Immunol Methods. 2014 Jul;409:9-20. doi: 10.1016/j.jim.2014.03.024. Epub 2014 Apr 4.","Ducar C","J Immunol Methods","2014","2014/04/09","PMC4195741","NIHMS588079","10.1016/j.jim.2014.03.024"
"25253665","Phase I/II randomized trial of safety and immunogenicity of LIPO-5 alone, ALVAC-HIV (vCP1452) alone, and ALVAC-HIV (vCP1452) prime/LIPO-5 boost in healthy, HIV-1-uninfected adult participants","Frey SE, Peiperl L, McElrath MJ, Kalams S, Goepfert PA, Keefer MC, Baden LR, Lally MA, Mayer K, Blattner WA, Harro CD, Hammer SM, Gorse GJ, Hural J, Tomaras GD, Levy Y, Gilbert P, deCamp A, Russell ND, Elizaga M, Allen M, Corey L.","Clin Vaccine Immunol. 2014 Nov;21(11):1589-99. doi: 10.1128/CVI.00450-14. Epub 2014 Sep 24.","Frey SE","Clin Vaccine Immunol","2014","2014/09/26","PMC4248765","","10.1128/CVI.00450-14"
"21451004","A trimeric, V2-deleted HIV-1 envelope glycoprotein vaccine elicits potent neutralizing antibodies but limited breadth of neutralization in human volunteers","Spearman P, Lally MA, Elizaga M, Montefiori D, Tomaras GD, McElrath MJ, Hural J, De Rosa SC, Sato A, Huang Y, Frey SE, Sato P, Donnelly J, Barnett S, Corey LJ; HIV Vaccine Trials Network of NIAID.","J Infect Dis. 2011 Apr 15;203(8):1165-73. doi: 10.1093/infdis/jiq175.","Spearman P","J Infect Dis","2011","2011/04/01","PMC3068023","","10.1093/infdis/jiq175"
"24403557","Specificity and 6-month durability of immune responses induced by DNA and recombinant modified vaccinia Ankara vaccines expressing HIV-1 virus-like particles","Goepfert PA, Elizaga ML, Seaton K, Tomaras GD, Montefiori DC, Sato A, Hural J, DeRosa SC, Kalams SA, McElrath MJ, Keefer MC, Baden LR, Lama JR, Sanchez J, Mulligan MJ, Buchbinder SP, Hammer SM, Koblin BA, Pensiero M, Butler C, Moss B, Robinson HL; HVTN 205 Study Group; National Institutes of Allergy and Infectious Diseases HIV Vaccines Trials Network.","J Infect Dis. 2014 Jul 1;210(1):99-110. doi: 10.1093/infdis/jiu003. Epub 2014 Jan 7.","Goepfert PA","J Infect Dis","2014","2014/01/10","PMC4072895","","10.1093/infdis/jiu003"
"23840043","Safety and comparative immunogenicity of an HIV-1 DNA vaccine in combination with plasmid interleukin 12 and impact of intramuscular electroporation for delivery","Kalams SA, Parker SD, Elizaga M, Metch B, Edupuganti S, Hural J, De Rosa S, Carter DK, Rybczyk K, Frank I, Fuchs J, Koblin B, Kim DH, Joseph P, Keefer MC, Baden LR, Eldridge J, Boyer J, Sherwat A, Cardinali M, Allen M, Pensiero M, Butler C, Khan AS, Yan J, Sardesai NY, Kublin JG, Weiner DB; NIAID HIV Vaccine Trials Network.","J Infect Dis. 2013 Sep 1;208(5):818-29. doi: 10.1093/infdis/jit236. Epub 2013 Jul 8.","Kalams SA","J Infect Dis","2013","2013/07/11","PMC3733506","","10.1093/infdis/jit236"
"21857901","A phase IIA randomized clinical trial of a multiclade HIV-1 DNA prime followed by a multiclade rAd5 HIV-1 vaccine boost in healthy adults (HVTN204)","Churchyard GJ, Morgan C, Adams E, Hural J, Graham BS, Moodie Z, Grove D, Gray G, Bekker LG, McElrath MJ, Tomaras GD, Goepfert P, Kalams S, Baden LR, Lally M, Dolin R, Blattner W, Kalichman A, Figueroa JP, Pape J, Schechter M, Defawe O, De Rosa SC, Montefiori DC, Nabel GJ, Corey L, Keefer MC; NIAID HIV Vaccine Trials Network.","PLoS One. 2011;6(8):e21225. doi: 10.1371/journal.pone.0021225. Epub 2011 Aug 3.","Churchyard GJ","PLoS One","2011","2011/08/23","PMC3152265","","10.1371/journal.pone.0021225"
"22242162","Safety and immunogenicity of an HIV-1 gag DNA vaccine with or without IL-12 and/or IL-15 plasmid cytokine adjuvant in healthy, HIV-1 uninfected adults","Kalams SA, Parker S, Jin X, Elizaga M, Metch B, Wang M, Hural J, Lubeck M, Eldridge J, Cardinali M, Blattner WA, Sobieszczyk M, Suriyanon V, Kalichman A, Weiner DB, Baden LR; NIAID HIV Vaccine Trials Network.","PLoS One. 2012;7(1):e29231. doi: 10.1371/journal.pone.0029231. Epub 2012 Jan 5.","Kalams SA","PLoS One","2012","2012/01/14","PMC3252307","","10.1371/journal.pone.0029231"
"20888337","Optimization of storage and shipment of cryopreserved peripheral blood mononuclear cells from HIV-infected and uninfected individuals for ELISPOT assays","Weinberg A, Song LY, Wilkening CL, Fenton T, Hural J, Louzao R, Ferrari G, Etter PE, Berrong M, Canniff JD, Carter D, Defawe OD, Garcia A, Garrelts TL, Gelman R, Lambrecht LK, Pahwa S, Pilakka-Kanthikeel S, Shugarts DL, Tustin NB.","J Immunol Methods. 2010 Dec 15;363(1):42-50. doi: 10.1016/j.jim.2010.09.032. Epub 2010 Oct 1.","Weinberg A","J Immunol Methods","2010","2010/10/05","PMC3068047","NIHMS245875","10.1016/j.jim.2010.09.032"
"23370155","Does participation in an HIV vaccine efficacy trial affect risk behaviour in South Africa?","Gray GE, Metch B, Churchyard G, Mlisana K, Nchabeleng M, Allen M, Moodie Z, Kublin J, Bekker LG; HVTN 503 team.","Vaccine. 2013 Apr 12;31(16):2089-96. doi: 10.1016/j.vaccine.2013.01.031. Epub 2013 Jan 29.","Gray GE","Vaccine","2013","2013/02/02","PMC3942784","NIHMS487911","10.1016/j.vaccine.2013.01.031"
"12077288","Identification of naturally processed CD4 T cell epitopes from the prostate-specific antigen kallikrein 4 using peptide-based in vitro stimulation","Hural JA, Friedman RS, McNabb A, Steen SS, Henderson RA, Kalos M.","J Immunol. 2002 Jul 1;169(1):557-65. doi: 10.4049/jimmunol.169.1.557.","Hural JA","J Immunol","2002","2002/06/22","","","10.4049/jimmunol.169.1.557"
"29136037","Safety, pharmacokinetics, and immunological activities of multiple intravenous or subcutaneous doses of an anti-HIV monoclonal antibody, VRC01, administered to HIV-uninfected adults: Results of a phase 1 randomized trial","Mayer KH, Seaton KE, Huang Y, Grunenberg N, Isaacs A, Allen M, Ledgerwood JE, Frank I, Sobieszczyk ME, Baden LR, Rodriguez B, Van Tieu H, Tomaras GD, Deal A, Goodman D, Bailer RT, Ferrari G, Jensen R, Hural J, Graham BS, Mascola JR, Corey L, Montefiori DC; HVTN 104 Protocol Team; and the NIAID HIV Vaccine Trials Network.","PLoS Med. 2017 Nov 14;14(11):e1002435. doi: 10.1371/journal.pmed.1002435. eCollection 2017 Nov.","Mayer KH","PLoS Med","2017","2017/11/15","PMC5685476","","10.1371/journal.pmed.1002435"
"24560541","Recombinant adenovirus type 5 HIV gag/pol/nef vaccine in South Africa: unblinded, long-term follow-up of the phase 2b HVTN 503/Phambili study","Gray GE, Moodie Z, Metch B, Gilbert PB, Bekker LG, Churchyard G, Nchabeleng M, Mlisana K, Laher F, Roux S, Mngadi K, Innes C, Mathebula M, Allen M, McElrath MJ, Robertson M, Kublin J, Corey L; HVTN 503/Phambili study team.","Lancet Infect Dis. 2014 May;14(5):388-96. doi: 10.1016/S1473-3099(14)70020-9. Epub 2014 Feb 20.","Gray GE","Lancet Infect Dis","2014","2014/02/25","PMC4174314","NIHMS588579","10.1016/S1473-3099(14)70020-9"
"21570355","Safety and efficacy of the HVTN 503/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study","Gray GE, Allen M, Moodie Z, Churchyard G, Bekker LG, Nchabeleng M, Mlisana K, Metch B, de Bruyn G, Latka MH, Roux S, Mathebula M, Naicker N, Ducar C, Carter DK, Puren A, Eaton N, McElrath MJ, Robertson M, Corey L, Kublin JG; HVTN 503/Phambili study team.","Lancet Infect Dis. 2011 Jul;11(7):507-15. doi: 10.1016/S1473-3099(11)70098-6. Epub 2011 May 11.","Gray GE","Lancet Infect Dis","2011","2011/05/17","PMC3417349","NIHMS357717","10.1016/S1473-3099(11)70098-6"
